Greg Andrew Durm

4.8k citations
51 papers · 3.0k · 5 hit papers · h-index 15

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 13
    • Lung Cancer Research Studies 5
    • Colorectal Cancer Treatments and Studies 5
    • Lung Cancer Treatments and Mutations 13
    • Lung Cancer Diagnosis and Treatment 7

Greg Andrew Durm

45 papers receiving 2.9k citations

Greg Andrew Durm's Hit Papers

NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025 2025 · 51 citations
510+2+4Years since publication4008001.2k

Peers

Greg Andrew Durm
Comparison fields: 5 of 94
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.0k
  • Cancer Research 409
  • Molecular Biology 791
  • Pathology and Forensic Medicine 160
Replace Alex Friedlaender with:
Alex Friedlaender Switzerland
Monica Ganzinelli Italy
Maria Giovanna Dal Bello Italy
Takehito Shukuya Japan
Saiama Naheed Waqar United States
Yun Fan China
Ramon Andrade de Mello Portugal
Eleni Andreopoulou United States
Luc Cabel France
Gianluca Spitaleri Italy
Greg Andrew Durm relative to Alex Friedlaender Switzerland Alex Friedlaender's profile →
Citations per field
00.5×1.5×1.9×
Alex Friedlaender · 1×
Citations per year

Countries citing papers authored by Greg Andrew Durm

Since Specialization
Citations

This map shows the geographic impact of Greg Andrew Durm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Andrew Durm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Andrew Durm more than expected).

Fields of papers citing papers by Greg Andrew Durm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Andrew Durm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Andrew Durm. The network helps show where Greg Andrew Durm may publish in the future.

Co-authors

The 25 scholars most cited alongside Greg Andrew Durm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Greg Andrew Durm Line = papers co-authored together Greg Andrew Durm links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
Hit paper breakdown →
20201339
2
Non–Small Cell Lung Cancer, Version 4.2024
Hit paper breakdown →
2024423
3
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
Hit paper breakdown →
2023339
4
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
Hit paper breakdown →
2022247
5 2020132
6 201974
7
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
Hit paper breakdown →
202551
8 201938
9 201932
10 202132
11 202525
12 202223
13 202020
14 202418
15 202317
16 202415
17 201613
18 202213
19 201911
20 202511

About Greg Andrew Durm

Greg Andrew Durm is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Cancer Research and Applied Psychology, having authored 51 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Head and Neck Cancer Studies (4 papers), Cancer Genomics and Diagnostics (3 papers) and Colorectal and Anal Carcinomas (3 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (409 citations), Molecular Biology (791 citations) and Pathology and Forensic Medicine (160 citations). Greg Andrew Durm has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Shadia Ibrahim Jalal, Hirva Mansurali Mamdani, Ahmed Bilal Khalid, Sandro Matosevic, Nasser H. Hanna, Sandra K. Althouse, Salma K. Jabbour, Adam Todd Hirsh, Catherine E. Mosher and Lawrence H. Einhorn. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Journal of Clinical Oncology, Annals of Oncology, Clinical Lung Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact